|
Certolizumab
|
Certolizumab |
|
|
glycolic_acid
|
glycolic_acid |
|
|
human immunodeficiency virus infections
|
GECCO_1.2.276.0.76.11.530 |
[HIV Infektionen im Rahmen von Covid-19, HIV infections in the context of Covid-19] |
|
Oxygen [Partial pressure] in Capillary blood
|
2704-5 |
|
|
N-sulfonylurea
|
N-sulfonylurea |
|
|
General_state_compromised
|
General_state_compromised |
|
|
Hyporeflexia
|
Hyporeflexia |
|
|
Abnormal_reflex
|
Abnormal_reflex |
|
|
Septation
|
Septation |
|
|
pleural_effusion
|
pleural_effusion |
|
|
Bedridden;_Rarely_Out_of_Bed
|
Bedridden;_Rarely_Out_of_Bed |
|
|
experiment
|
experiment |
|
|
Animal_dander_allergy
|
Animal_dander_allergy |
|
|
allergen
|
allergen |
|
|
Critical illness polyneuropathy
|
G62.81 |
[Critical illness polyneuropathy] |
|
Mild (qualifier value)
|
255604002 |
|
|
stage at diagnosis
|
GECCO_1.2.276.0.76.11.492 |
[Disease phase at diagnosis, Erkrankungsphase bei Diagnose von Covid-19] |
|
pneumothorax
|
pneumothorax |
|
|
Value Domain: Immunoglobulins
|
GECCO_2.16.840.1.113883.3.1937.777.53.2.1.2040.20200408000000.0 |
|
|
Microcytic_Red_Blood_Cell
|
Microcytic_Red_Blood_Cell |
|
